These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

50 related items for PubMed ID: 5151267

  • 1. [Dependence of the toxicity and antineoplastic activity of 5-fluorouracil solutions on the incubation time at 37 degrees].
    Merkulov MF, Leskova SG, Rudenskaia GN.
    Farmakol Toksikol; 1971; 34(5):621-6. PubMed ID: 5151267
    [No Abstract] [Full Text] [Related]

  • 2. Stability of fluorouracil in plastic containers used for continuous infusion at home.
    Quebbeman EJ, Hamid AA, Hoffman NE, Ausman RK.
    Am J Hosp Pharm; 1984 Jun; 41(6):1153-6. PubMed ID: 6741959
    [Abstract] [Full Text] [Related]

  • 3. The antileukemic effectiveness of 5-fluorouracil and methotrexate in the combination chemotherapy of advanced leukemia L1210 in mice.
    Kline I, Venditti JM, Mead JA, Tyrer DD, Goldin A.
    Cancer Res; 1966 May; 26(5):848-52. PubMed ID: 5934795
    [No Abstract] [Full Text] [Related]

  • 4. Potentiation of 5-fluorouracil efficacy by the dihydrouracil dehydrogenase inhibitor, 5-benzyloxybenzyluracil.
    Naguib FN, Hao SN, el Kouni MH.
    Cancer Res; 1994 Oct 01; 54(19):5166-70. PubMed ID: 7923135
    [Abstract] [Full Text] [Related]

  • 5. In vitro antileukemic activity and chemical transformation of the 5'-chloro-5'-deoxy derivative of cyclocytidine.
    Stankovicová M, Rauko P, Bachratá M, Blesová M, Sveda P.
    Neoplasma; 1995 Oct 01; 42(5):255-8. PubMed ID: 8552205
    [Abstract] [Full Text] [Related]

  • 6. Combined effect of 5-fluorouracil and carboplatin against human gastric cancer cell lines in vitro and in vivo.
    Saikawa Y, Kubota T, Kuo TH, Tanino H, Kase S, Furukawa T, Watanabe M, Ishibiki K, Kitajima M, Hoffman RM.
    Anticancer Res; 1994 Oct 01; 14(2A):461-4. PubMed ID: 8017848
    [Abstract] [Full Text] [Related]

  • 7. Novel thermosensitive 5-fluorouracil-cyclotriphosphazene conjugates: synthesis, thermosensitivity, degradability, and in vitro antitumor activity.
    Cho YW, Lee JR, Song SC.
    Bioconjug Chem; 2005 Oct 01; 16(6):1529-35. PubMed ID: 16287251
    [Abstract] [Full Text] [Related]

  • 8. Development and assessment of novel all-in-one parenteral formulations with integrated anticoagulant properties for the concomitant delivery of 5-fluorouracil and calcium folinate.
    Locke JM, Stutchbury TK, Vine KL, Gamble AB, Clingan PR, Bremner JB, Ranson M.
    Anticancer Drugs; 2009 Oct 01; 20(9):822-31. PubMed ID: 19606016
    [Abstract] [Full Text] [Related]

  • 9. Regulation of RNA- and DNA-directed actions of 5-fluoropyrimidines in mouse T-lymphoma (S-49) cells.
    Maybaum J, Ullman B, Mandel HG, Day JL, Sadee W.
    Cancer Res; 1980 Nov 01; 40(11):4209-15. PubMed ID: 6451283
    [Abstract] [Full Text] [Related]

  • 10. [Alteration products of thiamine in injectable solutions and their acute and sub-chronic toxicity].
    Gaudiano A, Petti G, Polizzi M, Tartarini S.
    Ann Ist Super Sanita; 1966 Nov 01; 2(4):537-9. PubMed ID: 6004800
    [No Abstract] [Full Text] [Related]

  • 11. Circadian rhythm and 5-fluorouracil toxicity in C3H mice.
    Popovic P, Popovic V, Baughman J.
    Prog Clin Biol Res; 1982 Nov 01; 107():185-7. PubMed ID: 7167477
    [Abstract] [Full Text] [Related]

  • 12. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine.
    Cao S, McGuire JJ, Rustum YM.
    Clin Cancer Res; 1999 Jul 01; 5(7):1925-34. PubMed ID: 10430100
    [Abstract] [Full Text] [Related]

  • 13. 5-Fluorouracil incorporation into DNA of CF-1 mouse bone marrow cells as a possible mechanism of toxicity.
    Schuetz JD, Wallace HJ, Diasio RB.
    Cancer Res; 1984 Apr 01; 44(4):1358-63. PubMed ID: 6704957
    [Abstract] [Full Text] [Related]

  • 14. Spectrophotometric analysis for fluorouracil in biological fluids.
    Morimoto Y, Akimoto M, Sugibayashi K, Nadai T, Kato Y.
    Pharmazie; 1981 Apr 01; 36(2):155-6. PubMed ID: 7232487
    [Abstract] [Full Text] [Related]

  • 15. The effect of 5-fluorouracil on the synthesis and methylation of low molecular weight nuclear RNA in L1210 cells.
    Glazer RI, Hartman KD.
    Mol Pharmacol; 1980 Mar 01; 17(2):245-9. PubMed ID: 7393205
    [No Abstract] [Full Text] [Related]

  • 16. S-phase dependent cytogenetic toxicity of 5-fluorouracil in bone marrow cells of mice.
    Choudhury RC, Misra S, Jagdale MB, Palo AK.
    J Exp Clin Cancer Res; 2001 Mar 01; 20(1):57-62. PubMed ID: 11370831
    [Abstract] [Full Text] [Related]

  • 17. Stem cells of GATA1-related leukemia undergo pernicious changes after 5-fluorouracil treatment.
    Abe K, Shimizu R, Pan X, Hamada H, Yoshikawa H, Yamamoto M.
    Exp Hematol; 2009 Apr 01; 37(4):435-445.e1. PubMed ID: 19302918
    [Abstract] [Full Text] [Related]

  • 18. Influence of ribose donors on the action of 5-fluorouracil.
    Kessel D, Hall TC.
    Cancer Res; 1969 Oct 01; 29(10):1749-54. PubMed ID: 5350077
    [No Abstract] [Full Text] [Related]

  • 19. 5-fluorouracil.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1981 May 01; 26():217-35. PubMed ID: 6944260
    [No Abstract] [Full Text] [Related]

  • 20. Hematoporphyrin derivative rescue from toxicity caused by chemotherapy or radiation in a murine leukemia model (L1210).
    Canti G, Franco P, Marelli O, Ricci L, Nicolin A.
    Cancer Res; 1984 Apr 01; 44(4):1551-6. PubMed ID: 6231100
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.